<unk>  is a bisphosphonate medication used in the prevention and treatment of osteoporosis and metastasis-associated skeletal fractures in people with cancer. It may also be used to treat hypercalcemia (elevated blood calcium levels). It is typically formulated as its sodium salt ibandronate sodium. It was patented in 1986 by Boehringer Mannheim and approved for medical use in 1996.
Ibandronic acid
Medronic acid
Risedronic acid
Alendronic acid
Pamidronic acid
Zoledronic acid
Bolazine capronate
Etidronic acid